Analyst Wire.

Earnings Wire → — just-reported prints vs consensus & the forward calendar, on the same hub.  ·  Daily archive → — every prior day's wire, one frozen page per close.

The latest calls, newest first

1. Target COIN Barclays Oct 7

   Target set to $149 (-19.8% to spot) · source ↗

   Ours Above its 50- & 200-day Street $210 (+13.3%)

2. Target RCKT Jefferies Oct 7

   Target set to $2.95 (+19% to spot) · source ↗

3. PT cut BLK Barclays Oct 7

   Target cut to $1420 from $1450 (+31.6% to spot) · source ↗

   Ours Below 50-day, above 200-day Street $1325 (+22.8%)

4. PT raised BRKR Barclays Oct 7

   Target raised to $70 from $58 (+15.7% to spot) · source ↗

   Ours Above its 50- & 200-day Street $64 (+5.1%)

5. PT raised ELV Barclays Oct 7

   Target raised to $469 from $457 (+17.2% to spot) · source ↗

   Ours Above its 50- & 200-day Street $444 (+11%)

6. PT raised JXN Barclays Oct 7

   Target raised to $150 from $149 (+12.9% to spot) · source ↗

   Ours Above its 50- & 200-day Street $141 (+6.3%)

7. Upgrade KR Exane BNP Paribas Oct 7

   Upgraded to Outperform from Neutral · source ↗

   Ours Above 50-day, below 200-day Street $71 (+20.7%)

8. Downgrade MHK RBC Capital Oct 7

   Downgraded to Underperform from Sector Perform · source ↗

   Ours Below 50-day, above 200-day Street $136 (+7.7%)

9. Upgrade MC UBS Oct 7

   Upgraded to Neutral from Sell · source ↗

10. Upgrade ALL HSBC Oct 7

    Upgraded to Buy from Hold · source ↗

    Ours Below 50-day, above 200-day Street $268 (+19.5%)

11. Upgrade MRVL Cowen & Co. Oct 7

    Upgraded to Buy from Hold · source ↗

    Ours Rubin Jensen Above its 50- & 200-day Street $294 (+2.6%)

12. Downgrade APPF UBS Oct 7

    Downgraded to Neutral from Buy · source ↗

    Ours Below 50-day, above 200-day Street $243 (+19.5%)

13. Upgrade XPO Citigroup Oct 7

    Upgraded to Buy from Neutral · source ↗

    Ours Below its 50- & 200-day Street $230 (+25.3%)

14. Downgrade E Exane BNP Paribas Oct 7

    Downgraded to Neutral from Outperform · source ↗

    Ours Below 50-day, above 200-day Street $77 (+41.4%)

15. Initiate SOLS Seaport Global Oct 7

    Initiated to Buy · source ↗

16. Initiate ATAT HSBC Oct 7

    Initiated to Buy · Target set to $39.7 (+23.3% to spot) · source ↗

17. Initiate HONA Goldman Sachs Oct 7

    Initiated to Neutral · source ↗

    Ours Below its 50- & 200-day Street $217 (+37.7%)

18. Downgrade SP Macquarie Oct 7

    Downgraded to Underperform from Neutral · source ↗

19. Upgrade FLUT Citigroup Oct 7

    Upgraded to Buy from Neutral · source ↗

    Ours Below its 50- & 200-day Street $133 (+74.6%)

20. Initiate AMBQ Jefferies Oct 7

    Initiated to Buy · source ↗

21. Upgrade CTVA KeyBanc Oct 7

    Upgraded to Overweight from Sector Weight · source ↗

    Ours Below its 50- & 200-day Street $60 (+328.8%)

22. Downgrade OC RBC Capital Oct 7

    Downgraded to Sector Perform from Outperform · source ↗

    Ours Below its 50- & 200-day Street $167 (+39.4%)

23. Downgrade NA UBS Oct 7

    Downgraded to Sell from Neutral · source ↗

24. Initiate VYLR KeyBanc Oct 7

    Initiated to Sector Weight · source ↗

25. Downgrade OPCH Citigroup Oct 7

    Downgraded to Perform from Market Perform · source ↗

26. Downgrade CRBU RBC Capital Oct 7

    Downgraded to Sector Perform from Buy · source ↗

27. Target NYAX Jefferies Oct 7

    Target set to $68.3 (+41.4% to spot) · source ↗

28. Downgrade OPCH Citigroup Oct 6

    Downgraded to Market Perform from Market Outperform · source ↗

29. Upgrade NEXA Morgan Stanley Oct 6

    Upgraded to Overweight from Underweight · Target set to $14.2 (+14.1% to spot) · source ↗

30. PT raised COP Jefferies Oct 6

    Target raised to $174 from $159 (+34.5% to spot) · source ↗

    Ours Above its 50- & 200-day Street $154 (+19.1%)

31. PT raised MRVL Jefferies Oct 6

    Target raised to $450 from $325 (+56.8% to spot) · source ↗

    Ours Rubin Jensen Above its 50- & 200-day Street $294 (+2.6%)

32. PT cut HE Jefferies Oct 6

    Target cut to $7 from $8.75 (-21.6% to spot) · source ↗

    Ours Below its 50- & 200-day Street $8 (-10.4%)

33. PT raised NTAP Goldman Sachs Oct 6

    Target raised to $240 from $210 (+5.1% to spot) · source ↗

    Ours AEI Above its 50- & 200-day Street $206 (-9.7%)

34. Target IVZ Buy from Neutral at UBS Oct 6

    Target set to $41 (+35% to spot) · source ↗

    Ours Below 50-day, above 200-day Street $34 (+11%)

35. PT cut VEL BTIG Oct 6

    Target cut to $20 from $22 (+34.5% to spot) · source ↗

36. PT cut RWT BTIG Oct 6

    Target cut to $5 from $6 (+45.3% to spot) · source ↗

37. PT cut MFA BTIG Oct 6

    Target cut to $9.5 from $10.5 (+30.5% to spot) · source ↗

38. PT cut DX BTIG Oct 6

    Target cut to $12 from $14.5 (+10.6% to spot) · source ↗

39. PT cut NLY BTIG Oct 6

    Target cut to $21 from $24 (+14% to spot) · source ↗

    Ours Below its 50- & 200-day Street $22 (+19.4%)

40. PT cut AOMR BTIG Oct 6

    Target cut to $9 from $10 (+22% to spot) · source ↗

41. Target CFG Raymond James Oct 6

    Target set to $77 (+20.1% to spot) · source ↗

    Ours Below its 50- & 200-day Street $79 (+23.8%)

42. Target CRCL US Tiger Securities Oct 6

    Target set to $115 (+36.7% to spot) · source ↗

    Ours Above 50-day, below 200-day Street $94 (+12.2%)

43. PT cut VOYG Jefferies Oct 6

    Target cut to $55 from $65 (+78.2% to spot) · source ↗

    Ours Below its 50- & 200-day Street $52 (+69.7%)

44. PT cut AVBP Jefferies Oct 6

    Target cut to $18 from $45 (+19.3% to spot) · source ↗

45. PT cut AVBP Truist Oct 6

    Target cut to $18 from $45 (+19.3% to spot) · source ↗

46. PT raised MRVL Evercore ISI Oct 6

    Target raised to $433 from $275 (+50.9% to spot) · source ↗

    Ours Rubin Jensen Above its 50- & 200-day Street $294 (+2.6%)

47. Target MTB Raymond James Oct 6

    Target set to $250 (+14.3% to spot) · source ↗

    Ours Below its 50- & 200-day Street $259 (+18.4%)

48. Target ABT Barclays Oct 6

    Target set to $120 (+22.2% to spot) · source ↗

    Ours Below its 50- & 200-day Street $120 (+22.2%)

49. Target ALC Barclays Oct 6

    Target set to $70 (+10.8% to spot) · source ↗

50. Target AVR Barclays Oct 6

    Target set to $10 (+41.8% to spot) · source ↗

51. Target AXGN Barclays Oct 6

    Target set to $55 (+51.5% to spot) · source ↗

52. Target BLCO Barclays Oct 6

    Target set to $24 (+39.7% to spot) · source ↗

    Ours Above its 50- & 200-day Street $21 (+21.2%)

53. Target BAX Barclays Oct 6

    Target set to $20 (-17.9% to spot) · source ↗

    Ours Below 50-day, above 200-day Street $24 (-3.1%)

54. Target BBNX Barclays Oct 6

    Target set to $30 (+61% to spot) · source ↗

55. Target BSX Barclays Oct 6

    Target set to $48 (+13.8% to spot) · source ↗

    Ours Below its 50- & 200-day Street $63 (+48.6%)

56. Target DXCM Barclays Oct 6

    Target set to $115 (+37.9% to spot) · source ↗

    Ours HALO Below 50-day, above 200-day Street $95 (+14%)

57. Initiate EW Barclays Oct 6

    Initiated to Overweight from Overweight · source ↗

    Ours Below 50-day, above 200-day Street $102 (+17.6%)

58. Target GEHC Barclays Oct 6

    Target set to $85 (+31.2% to spot) · source ↗

    Ours HALO Below its 50- & 200-day Street $81 (+24.3%)

59. Initiate HUMA Barclays Oct 6

    Initiated to Positive from Overweight · source ↗

60. Target INSP Barclays Oct 6

    Target set to $65 (-4.7% to spot) · source ↗

61. Target PODD Barclays Oct 6

    Target set to $150 (+11.3% to spot) · source ↗

    Ours Below its 50- & 200-day Street $182 (+35.3%)

62. Target ISRG Barclays Oct 6

    Target set to $485 (+19.8% to spot) · source ↗

    Ours HALO Above 50-day, below 200-day Street $481 (+18.8%)

63. Target LIVN Barclays Oct 6

    Target set to $105 (+40.1% to spot) · source ↗

64. Target MDT Barclays Oct 6

    Target set to $95 (+9.1% to spot) · source ↗

    Ours Below its 50- & 200-day Street $98 (+12.3%)

65. Target MMED Barclays Oct 6

    Target set to $22 (+12% to spot) · source ↗

    Ours Below 50-day, above 200-day Street $25 (+29.5%)

66. Target PRCT Barclays Oct 6

    Target set to $30 (+71.3% to spot) · source ↗

67. Target SENS Barclays Oct 6

    Target set to $10 (+0.4% to spot) · source ↗

68. Target SYK Barclays Oct 6

    Target set to $375 (+34.6% to spot) · source ↗

    Ours HALO Below its 50- & 200-day Street $368 (+32.3%)

69. Target TNDM Barclays Oct 6

    Target set to $18 (+11.4% to spot) · source ↗

    Ours Below its 50- & 200-day Street $26 (+61.3%)

70. Target COO Barclays Oct 6

    Target set to $60 (+6.3% to spot) · source ↗

    Ours Below its 50- & 200-day Street $65 (+15.4%)

71. Target TMDX Barclays Oct 6

    Target set to $120 (+49.5% to spot) · source ↗

72. Initiate ZBH Barclays Oct 6

    Initiated to Positive from Underweight · source ↗

    Ours Below its 50- & 200-day Street $103 (+15%)

73. Downgrade OPCH Jefferies Oct 6

    Downgraded to Hold from Buy · Target set to $32.05 (+3.4% to spot) · source ↗

74. PT raised PFE Scotiabank Oct 6

    Target raised to $33 from $30 (+20.9% to spot) · source ↗

    Ours Above its 50- & 200-day Street $29 (+6.9%)

75. PT cut SYK Truist Oct 6

    Target cut to $310 from $340 (+10.6% to spot) · source ↗

    Ours HALO Below its 50- & 200-day Street $368 (+32.3%)

76. Initiate VERU WestPark Capital Oct 6

    Initiated to Buy · source ↗

77. Upgrade HUBS UBS Oct 6

    Upgraded to Positive from Outperform · source ↗

    Ours AW40 Below its 50- & 200-day Street $244 (+12.2%)

78. PT cut NVS Morgan Stanley Oct 6

    Target cut to $156 from $170 (+10.8% to spot) · source ↗

79. PT raised AMZN Tigress Financial Oct 6

    Target raised to $385 from $315 (+50.8% to spot) · source ↗

    Ours AW40 T1 Below 50-day, above 200-day Street $329 (+28.3%)

80. Target CHRD UBS Oct 6

    Target set to $193 (+39.4% to spot) · source ↗

    Ours Below 50-day, above 200-day Street $173 (+25.4%)

No analyst calls match your filter.

Sources and how to read the wire

Analyst data via Financial Modeling Prep (US-listed names); our technical read & index/portfolio membership are computed from the Closelooknet data lake and books. For information only — a feed of third-party sell-side actions with our own context, not investment advice or a recommendation. Ratings, targets and the upside-to-spot are point-in-time; tap the source for the analyst’s full note.